Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Zydus Wellness's interest expense for the
three
months ended in Jun. 2026 was ₹ -263 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹-1,219 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Zydus Wellness Interest Expense Historical Data
* Premium members only.
The historical data trend for Zydus Wellness's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-1,219 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zydus Wellness (BOM:531335) has a Interest Expense of ₹-1,219 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Zydus Wellness and its competitors.
Is Zydus Wellness' Interest Expense too high?
Zydus Wellness' current Interest Expense is ₹-1,219 Mil. Overall, Zydus Wellness has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zydus Wellness' Interest Expense compare to KHC and GIS?
Zydus Wellness' Interest Expense of ₹-1,219 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Consumer Packaged Goods company?
A good Interest Expense depends on the Consumer Packaged Goods industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Zydus Wellness and its competitors. Zydus Wellness's current Interest Expense is ₹-1,219 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zydus Wellness stock overvalued right now?
Based on GuruFocus' analysis, Zydus Wellness (BOM:531335) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹674.62, compared to a current price of ₹505.80 — trading 25% below its estimated fair value. The current Interest Expense is ₹-1,219 Mil. Zydus Wellness' overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Zydus Wellness (BOM:531335), the current Interest Expense is ₹-1,219 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zydus Wellness (BOM:531335) Overvalued in 2026?
Based on GuruFocus' analysis, Zydus Wellness stock appears to be undervalued.
The current stock price of ₹505.80 is trading 25% below its estimated GF Value™ of ₹674.62.
GuruFocus considers Zydus Wellness to be Modestly Undervalued.
Key valuation signals for BOM:531335:
Interest Expense: ₹-1,219 Mil
GF Value™: ₹674.62 vs. price of ₹505.80 (25% below fair value)
No single metric tells the full story. See the BOM:531335 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zydus Wellness Ltd is engaged in the production and distribution of health and wellness products. It has several brands, including Everyuth, Sugar-Free, and Nutralite. The company offers specialty skincare products under the brand Everyuth Naturals. Zydus's sugar-free product portfolio, a sugar substitute category, consists of Sugar-Free gold for tabletop usage and Sugar-Free Natura for culinary usage. The firm also offers healthy foods, including Nutralite, a healthy butter substitute. Company brands includes: Complan, Sugar Free, Glucon-D, Everyuth, Nycil, Nutralite, and Others.
85GF Score
Get the complete analysis for BOM:531335
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531335 has been successfully added to your 
